- Home
- PUMP vs TRDA Comparison
PUMP vs TRDA Comparison
Compare PUMP & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PUMP
- TRDA
- Stock Information
- Founded
- PUMP 2007
- TRDA 2016
- Country
- PUMP United States
- TRDA United States
- Employees
- PUMP N/A
- TRDA N/A
- Industry
- PUMP Oilfield Services/Equipment
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- PUMP Energy
- TRDA Health Care
- Exchange
- PUMP Nasdaq
- TRDA Nasdaq
- Market Cap
- PUMP 719.0M
- TRDA 609.7M
- IPO Year
- PUMP 2017
- TRDA 2021
- Fundamental
- Price
- PUMP $7.57
- TRDA $17.85
- Analyst Decision
- PUMP Buy
- TRDA Strong Buy
- Analyst Count
- PUMP 6
- TRDA 3
- Target Price
- PUMP $11.00
- TRDA $23.33
- AVG Volume (30 Days)
- PUMP 1.3M
- TRDA 132.5K
- Earning Date
- PUMP 10-30-2024
- TRDA 11-05-2024
- Dividend Yield
- PUMP N/A
- TRDA N/A
- EPS Growth
- PUMP N/A
- TRDA N/A
- EPS
- PUMP N/A
- TRDA 1.55
- Revenue
- PUMP $1,471,508,000.00
- TRDA $215,232,000.00
- Revenue This Year
- PUMP N/A
- TRDA $47.63
- Revenue Next Year
- PUMP N/A
- TRDA N/A
- P/E Ratio
- PUMP N/A
- TRDA $11.51
- Revenue Growth
- PUMP N/A
- TRDA 146.92
- 52 Week Low
- PUMP $6.54
- TRDA $10.75
- 52 Week High
- PUMP $10.02
- TRDA $20.49
- Technical
- Relative Strength Index (RSI)
- PUMP 47.42
- TRDA 48.42
- Support Level
- PUMP $7.59
- TRDA $19.28
- Resistance Level
- PUMP $8.25
- TRDA $20.49
- Average True Range (ATR)
- PUMP 0.42
- TRDA 0.92
- MACD
- PUMP 0.04
- TRDA -0.01
- Stochastic Oscillator
- PUMP 53.21
- TRDA 25.21
About PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and coiled tubing.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.